Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Borgeson Blake received 88,424 Recursion Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 17, 2026 · Filed Jun 22, 2026
On Jun 17, 2026, Borgeson Blake (Director) received 88,424 Recursion Pharmaceuticals, Inc. shares as an award, leaving 6,258,287 shares. Filed Jun 22, 2026 (Form 4).
- Awarded
- 88,424 shares
- Holding after
- 6,258,287 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Class A Common Stock | Award | 88,424 | 6,258,287 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Borgeson Blake
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Borgeson Blake · Sep 2, 2026
- Form 4 · Borgeson Blake · Aug 6, 2026
- Form 4 · Borgeson Blake · Jul 9, 2026
- Form 4 · Borgeson Blake · Jun 4, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026
- Form 4 · Khan Najat · Sep 10, 2026